As obesity care continues to evolve, the Obesity Action Coalition (OAC), in partnership with the American Board of Obesity Medicine (ABOM) Foundation, has released Commit to Care: A Patient and Health ...

SAN DIEGO — Do patients with atrial fibrillation need oral anticoagulation (OAC) with a single antiplatelet therapy (APT) a year or more after receiving a coronary stent, or would OAC alone suffice? A ...

Jan. 6—John Carroll's time as a member of the Ohio Athletic Conference is reportedly coming to an end. According to a Jan. 5 report by Division III college basketball guru Bob Quillman of the Q-Cast, ...

High-bleeding-risk (HBR) patients taking an oral anticoagulant (OAC), as well as those who were not, had similar rates of ischemic and net adverse events in the MASTER DAPT trial, no matter whether ...

In the OCEANIC-AF trial, asundexian resulted in a small increase in the rates of stroke and lowered bleeding compared with apixaban in patients with atrial fibrillation (AF) who were naive to oral ...

Talk about a good day for the John Carroll men’s basketball team. On Feb. 23, the Ohio Athletic Conference released its men’s basketball awards and the No. 3-ranked and 24-2 Blue Streaks took home two ...

SAN DIEGO, CA—An attempt to clarify the best approach for antithrombotic therapy in patients with A-fib who are stable more than a year out from coronary stenting fell flat after slow enrollment led ...